Unitedhealth Group Inc (UNH) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Unitedhealth Group Inc (UNH) stock forecast summary
Our AI ranks Unitedhealth Group Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Unitedhealth Group Inc is a mega-cap company with a market capitalization of $339.76B. It ranks number 1 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast. Its Current Ratio of 0.78x is the lowest of the 10 peers that report one.
A per-ticker accuracy statistic for UNH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, UNH included.
Follow UNH freeUNH price chart and AI forecast
How UNH ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Unitedhealth Group Inc (UNH) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.
Valuation & Market
| Metric | UNH | Rank |
|---|---|---|
| Market Cap | $339.76B | 1/10 |
| P/E Ratio | 24.06x | 2/5 |
| P/B Ratio | 3.45x | 4/10 |
| Dividend Yield | 2.38% | – |
| EPS | $15.58 | – |
| Book Value/Share | $109.68 | – |
| Revenue/Share | $501.48 | – |
| FCF/Share | $26.31 | – |
Profitability & Margins
| Metric | UNH | Rank |
|---|---|---|
| ROE | 14.3% | 3/8 |
| ROA | 4.6% | 2/8 |
| ROIC | 10.9% | 2/10 |
| Gross Margin | 88.6% | 3/6 |
| Operating Margin | 4.8% | 1/10 |
| Net Margin | 3.1% | 2/8 |
| EBT Margin | 3.9% | 1/10 |
| Tax Rate | 14.5% | – |
Financial Health
| Metric | UNH | Rank |
|---|---|---|
| Current Ratio | 0.78x | 10/10 |
| D/E Ratio | 2.07x | 6/10 |
| Financial Leverage | 3.15x | 6/10 |
| Interest Coverage | 8.3x | 3/9 |
| Working Capital | -$24.96B | 10/10 |
Cash Flow
| Metric | UNH | Rank |
|---|---|---|
| Operating Cash Flow | $27.02B | 1/10 |
| Free Cash Flow | $23.62B | 1/9 |
| Capital Spending | -$3.40B | 9/9 |
| OCF Growth YoY | -6.7% | 7/9 |
| FCF Growth YoY | -6.5% | 6/8 |
| FCF/Sales | 5.2% | 3/9 |
| CapEx/Sales | 0.8% | 2/9 |
Operational Efficiency
| Metric | UNH | Rank |
|---|---|---|
| Asset Turnover | 1.45x | 9/10 |
| Receivables Turnover | 20.9x | 3/6 |
| Fixed Assets Turnover | 41.8x | 9/10 |
| Days Sales Outstanding | 17 days | 4/6 |
Income Statement
| Metric | UNH | Rank |
|---|---|---|
| Total Revenue | $450.13B | 1/10 |
| Operating Income | $21.68B | 1/10 |
| Net Income | $14.12B | 1/8 |
| SG&A Expense | $61.88B | 1/8 |
| Cost of Goods Sold | $51.44B | 2/6 |
Dividend & Shareholder Information
| Metric | UNH | Rank |
|---|---|---|
| Dividends Per Share | $9.02 | – |
| Payout Ratio | 57.9% | – |
| Shares Outstanding | 898M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $86.86B | 28.0% of assets |
| Cash & Short-term Investments | $28.59B | 9.2% of assets |
| Accounts Receivable | $21.57B | 7.0% of assets |
| Total Liabilities | $203.78B | 65.8% of assets |
UNH quarterly financials and insider trading
Unitedhealth Group Inc (UNH) industry peers
Companies classified under the same SEC industry code as Unitedhealth Group Inc (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| UNH Unitedhealth Group Inc | ▲ | $339.76B |
| ELV Elevance Health, Inc. | ▲ | $92.23B |
| CI Cigna Group | ▲ | $74.66B |
| HUM Humana Inc | ▲ | $50.47B |
| CNC Centene Corp | ▲ | $34.02B |
| MOH Molina Healthcare, Inc. | ▲ | $10.94B |
| OSCR Oscar Health, Inc. | ▲ | $10.43B |
| CLOV Clover Health Investments, Corp. /De | ▲ | $2.55B |
| ALHC Alignment Healthcare, Inc. | ▲ | $1.72B |
| TRUP Trupanion, Inc. | ▼ | $1.15B |
Where UNH sits on the market map
Unitedhealth Group Inc (UNH) stock news
Loading...
Unitedhealth Group Inc (UNH) stock forecast FAQ
What is the Unitedhealth Group Inc (UNH) stock forecast?
Our AI ranks Unitedhealth Group Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Unitedhealth Group Inc stock predictions?
A per-ticker accuracy statistic for UNH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Unitedhealth Group Inc forecasts updated?
Unitedhealth Group Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Unitedhealth Group Inc's industry peers?
10 issuers in our coverage, UNH included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Elevance Health, Inc. (ELV), Cigna Group (CI), Humana Inc (HUM), Centene Corp (CNC), Molina Healthcare, Inc. (MOH), Oscar Health, Inc. (OSCR).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.